Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Mikael Knutsson"'
Autor:
Yongjun Wang, S Claiborne Johnston, Pierre Amarenco, Carl Mellström, Mario Ouwens, Scott R Evans, Ritika Jain, Stefan James, Hans Denison, Per Ladenvall, Carlos A Molina, Anders Himmelmann, Mikael Knutsson, Amarjeet Tank, Klas Rikner
Publikováno v:
BMJ Neurology Open, Vol 5, Iss 2 (2023)
Objective THALES demonstrated that ticagrelor plus aspirin reduced the risk of stroke or death but increased bleeding versus aspirin during the 30 days following a mild-to-moderate acute non-cardioembolic ischaemic stroke (AIS) or high-risk transient
Externí odkaz:
https://doaj.org/article/ca42b3bf4bfc4422864b26bffd2bd5bc
Autor:
Johan Jirholt, Bengt Asling, Paul Hammond, Geoffrey Davidson, Mikael Knutsson, Anna Walentinsson, Jörgen M Jensen, Anders Lehmann, Lars Agreus, Maria Lagerström-Fermer
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e19095 (2011)
Gastro-esophageal reflux disease (GERD) is partly caused by genetic factors. The underlying susceptibility genes are currently unknown, with the exception of COL3A1. We used three independent GERD patient cohorts to identify GERD susceptibility genes
Externí odkaz:
https://doaj.org/article/3707b69c97d44eaf978b6be18b2e9934
Autor:
Florian Krackhardt, Magnus Jörnten-Karlsson, Matthias Waliszewski, Mikael Knutsson, Anna Niklasson, Karl-Friedrich Appel, Ralf Degenhardt, Alexander Ghanem, Till Köhler, Marc-Alexander Ohlow, Carsten Tschöpe, Heinz Theres, Jürgen vom Dahl, Björn W. Karlson, Lars S. Maier
Publikováno v:
Cardiovascular Drugs and Therapy.
Purpose This study evaluated whether patient support, administered via an electronic device-based app, increased adherence to treatment and lifestyle changes in patients with acute coronary syndrome (ACS) treated with ticagrelor in routine clinical p
Autor:
Florian, Krackhardt, Magnus, Jörnten-Karlsson, Matthias, Waliszewski, Mikael, Knutsson, Anna, Niklasson, Karl-Friedrich, Appel, Ralf, Degenhardt, Alexander, Ghanem, Till, Köhler, Marc-Alexander, Ohlow, Carsten, Tschöpe, Heinz, Theres, Jürgen, Vom Dahl, Björn W, Karlson, Lars S, Maier
Publikováno v:
Cardiovascular drugs and therapy.
This study evaluated whether patient support, administered via an electronic device-based app, increased adherence to treatment and lifestyle changes in patients with acute coronary syndrome (ACS) treated with ticagrelor in routine clinical practice.
Autor:
Yongjun Wang, Yuesong Pan, Hao Li, Pierre Amarenco, Hans Denison, Scott R. Evans, Anders Himmelmann, Stefan James, Mikael Knutsson, Per Ladenvall, Carlos A. Molina, S. Claiborne Johnston
Publikováno v:
Scientia
Background and ObjectivesThe goal of this work was to investigate the short-term time-course benefit and risk of ticagrelor with aspirin in acute mild-moderate ischemic stroke or high-risk TIA in The Acute Stroke or Transient Ischemic Attack Treated
Autor:
Hans Denison, Per Ladenvall, Mikael Knutsson, Donna Kurowski George, Scott E. Kasner, Brett Cucchiara, Pierre Amarenco, S. Claiborne Johnston
Publikováno v:
Neurology. 93:e708-e716
ObjectiveTo examine factors associated with disability following TIA and minor stroke, including poststroke complications such as stroke recurrence, major bleeding, and other adverse medical events.MethodsThe SOCRATES trial randomized patients with T
Autor:
Carlos A. Molina, Hans Denison, Ks Lawrence Wong, Scott R. Evans, Per Ladenvall, Pierre Amarenco, J. Donald Easton, Investigators, Yongjun Wang, Kazuo Minematsu, S. Claiborne Johnston, Mikael Knutsson, Gregory W. Albers
Publikováno v:
International Journal of Stroke. 14:908-914
Background Adjudication of endpoints is a standard procedure in cardiovascular clinical trials. However, several studies indicate that the benefit of adjudication in estimating treatment effect may be limited. Aims This post hoc analysis of SOCRATES
Publikováno v:
Economics Letters. 176:47-50
This paper reports new findings on gender differences in altruism. Conducting a natural field experiment (N = 2,164) we study donation behavior in a naturally occurring environment using a matched donation design. Contrary to previous research, we fi
Autor:
Anders Himmelmann, Sven Nylander, Maria Aunes, S. Claiborne Johnston, Carlos A. Molina, Scott R. Evans, Pierre Amarenco, Stefan James, Joachim Röther, Per Ladenvall, Mikael Knutsson, Marianne Jahreskog, Hans Denison, Yongjun Wang
Publikováno v:
Stroke. 52
Introduction: In the THALES trial, ticagrelor and aspirin was superior to aspirin alone in reducing the primary endpoint of stroke or death, and subsequent disabling strokes, but increased risk of bleeding, as expected for dual antiplatelet therapy.
Autor:
Sven Nylander, Anders Himmelmann, Joachim Röther, Per Ladenvall, S. Claiborne Johnston, Scott R. Evans, Carlos A. Molina, Marianne Jahreskog, Yongjun Wang, Mikael Knutsson, Hans Denison, Maria Aunes, Pierre Amarenco, Stefan James
Publikováno v:
Stroke
Supplemental Digital Content is available in the text.
Background and Purpose: In patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack, the THALES trial (Acute Stroke or Transient Ischemic Attack Treated With
Background and Purpose: In patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack, the THALES trial (Acute Stroke or Transient Ischemic Attack Treated With
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::663a1e9b9310db37ea05b9d95f2298aa
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-458771
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-458771